"UM Shore Medical Center at Easton provides inpatient and outpatient services for a broad range of primary and secondary care services."

During the past decade, University of Maryland Shore Medical Center at Easton conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 22 clinical trials were completed, i.e. on average, 78.6% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 10 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Maryland Shore Medical Center at Easton" #1 sponsor was "National Cancer Institute (NCI)" with 28 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "NRG Oncology" with 5 trials sponsored, "SWOG Cancer Research Network" with 5 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Maryland Shore Medical Center at Easton" #1 collaborator was "National Cancer Institute (NCI)" with 21 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator and "Canadian Cancer Trials Group" with 4 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "University of Maryland Shore Medical Center at Easton" are "Recurrent Breast Carcinoma" (6 trials), "Breast Adenocarcinoma" (4 trials), "HER2/Neu Negative" (4 trials), "Invasive Breast Carcinoma" (4 trials) and "Stage IV Breast Cancer AJCC v6 and v7" (4 trials). Many other conditions were trialed in "University of Maryland Shore Medical Center at Easton" in a lesser frequency.

Most popular intervention types in "University of Maryland Shore Medical Center at Easton" are "Drug" (46 trials), "Other" (35 trials), "Biological" (22 trials), "Procedure" (8 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Quality-of-Life Assessment" (18 trials), "Paclitaxel" (15 trials), "Carboplatin" (11 trials) and "Bevacizumab" (9 trials). Other intervention names were less common.

The vast majority of trials in "University of Maryland Shore Medical Center at Easton" are 34 trials for "All" genders, 15 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Maryland Shore Medical Center at Easton". undefined are not yet recruiting, 13 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in University of Maryland Shore Medical Center at Easton, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in University of Maryland Shore Medical Center at Easton, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

University of Maryland Shore Medical Center at Easton has several departments that took part in Clinical trials: "Shore Regional Cancer Center at Memorial Hospital - Easton" - 15 trials